European Society of Toxicology In Vitro > News > ESTIV and EUSAAT signed a Memorandum of Understanding
1 October 2022

ESTIV and EUSAAT signed a Memorandum of Understanding

The European Society of Toxicology in Vitro (ESTIV) and the European Society for Alternatives to Animal Testing EUSAAT signed a Memorandum of Understanding at the EUSAAT 2022 congress in Linz. The MoU aims to intensify collaboration between the two EU societies with a focus on the implementation of 3Rs and New Approach Methodologies (NAMs) into modern science, research and regulations. More information on the collaboration between the two societies will be announced at the ESTIV 2022 Congress in Barcelona-Sitges.

Related content

ESTIV: ASCCTTox.org/AnnualMeeting

Join scientists from across government, industry, academia, and NGOs to share science, discuss regulatory policies, and collaborate to advance toxicology…

Call for Abstracts ESTIV 2026!

We are pleased to announce that abstract submission for the 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026), is now possible!The general theme of the congress is “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs”.

Provisionally accepted sessions for the ESTIV 2026 Congress

We are pleased to announce that the Scientific Committee of the ESTIV2026 Congress has provisionally accepted 25 session proposals for the upcoming ESTIV 2026 Congress, which will take place in Maastricht, The Netherlands. With over 50 high-quality submissions received in the initial round, this marks an exciting milestone on the road to ESTIV’s flagship event.

Silver Sponsor

Memorandum of Understanding